Clinical Medicine Insights: Case Reports (Oct 2024)

A Death for Guillain-Barrè Syndrome After Receiving a COVID-19 Vaccine: A Case Report

  • Antonio Coviello,
  • Carmine Iacovazzo,
  • Maria Vargas,
  • Concetta Posillipo,
  • Francesco Sagnelli,
  • Pasquale Diglio,
  • Dario Cirillo,
  • Giuseppe Servillo

DOI
https://doi.org/10.1177/11795476241274692
Journal volume & issue
Vol. 17

Abstract

Read online

The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) causes COVID-19, a potentially fatal disease. The COVID-19 vaccine is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2. We reported the case of a 66-year-old woman with a medical history of hypertension and anxious-depressive syndrome who developed Guillain Barré Syndrome (GBS) 4 weeks after receiving the COVID-19 vaccine. During the patient’s hospital stay, they received cycles of high-dose intravenous immunoglobulin (IVIG) and plasmapheresis treatments.. Despite the treatment, a deterioration of respiratory function led the patient to premature mortality.